Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Cardiovascular Surgery Devices And Equipment Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The market encompassing devices and equipment for cardiovascular surgery has witnessed consistent expansion lately, progressing from a valuation of $1.76 billion in 2024 to an anticipated $1.8 billion by 2025, reflecting a compound annual growth rate (CAGR) of 2.7%; this upward trajectory throughout the past period is fundamentally linked to the increasing incidence of heart conditions, continuous technological progress, the demographic shift towards an older populace, and enhanced strategies for handling long-term illnesses.
The worldwide market for devices and apparatus utilized in cardiovascular surgery is projected to experience consistent expansion over the upcoming years, reaching a value of $1.97 billion by 2029, propelled by a compound annual growth rate (CAGR) of 2.2%; this upward trajectory in the projected timeframe is fundamentally supported by advancements such as less invasive surgical techniques, sophisticated imaging technologies, customized medical treatments, and the increasing adoption of telemedicine for remote consultations, while key developments shaping this period involve the integration of hybrid operating theaters, procedures performed via catheters, the application of artificial intelligence within surgical contexts, and the expansion of remote surgical instruction methods.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp
What Are The Key Drivers Of Growth In The Cardiovascular Surgery Devices And Equipment Market?
An increasing elderly demographic coupled with a growing mortality rate attributed to heart ailments is fueling the expansion of the market for cardiovascular surgical apparatus. Statistics provided by the American Heart Association (AHA) indicate that roughly 43.7 million individuals in the United States, aged sixty and over, were afflicted with cardiovascular conditions. Furthermore, the AHA has documented that fatalities stemming from heart diseases currently total 17.3 million annually, a figure projected to exceed 23.6 million globally by the year 2030. Consequently, the elevated frequency of surgical procedures necessitated by these trends is serving as a significant impetus for market growth.
What Are The Key Segments In The Cardiovascular Surgery Devices And Equipment Market?
The cardiovascular surgery devices and equipmentmarket covered in this report is segmented –
1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research Laboratories
Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables
Which Competitive Trends Are Defining The Cardiovascular Surgery Devices And Equipment Market Structure?
Significant capital is being directed by leading enterprises toward businesses active within the Cardiac Surgery Apparatus and Instrumentation sector, specifically those concentrating on pioneering technologies like CardioVisio for Atrial Fibrillation (AFib), with the objective of advancing preliminary identification methods, boosting patient recovery results, and simplifying therapeutic processes.CardioVisio for Atrial Fibrillation (AFib) constitutes a sophisticated system for both diagnosing and observing this prevalent irregular heartbeat condition. As a clear example, in August of 2023, US medical technology giant GE HealthCare released CardioVisio for Atrial Fibrillation (AFib), a new digital instrument designed to offer decision support for more precise management of individuals experiencing AFib. Unveiled during the ESC Congress 2023, this novel capability merges historical patient information sourced from numerous points, thus equipping healthcare providers with an exhaustive assessment of cardiac status; furthermore, by delivering suggestions rooted in evidence that conform to established AFib protocols, CardioVisio effectively simplifies medical procedures and elevates compliance with optimal standards of care.
Who Are The Major Companies Operating In The Cardiovascular Surgery Devices And Equipment Market?
Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.
Download The Full Report For Exclusive Market Findings:
Which Region Is Expected To Witness The Fastest Growth In The Cardiovascular Surgery Devices And Equipment Market?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2024. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Cardiovascular Surgery Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Surgery Devices And Equipment Market 2025, By The Business Research Company
Cardiovascular Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
Cardiovascular Medical Lasers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model